| Ana Paula Arruda, PhD | Liver Metabolism & Organ Cross-Talk | ER stress in metabolic liver disease |
| Jody L. Baron, MD, PhD | Liver Injury & Immunology | Hepatic immune responses in viral hepatitis and liver cancer |
| Michael Bokoch, MD, PhD | Liver Regeneration & Clinical Transplantation | Interventions to improve outcomes of liver transplant surgery |
| Laura N. Bull, PhD | Liver Injury & Immunology | Hereditary cholestatic disorders |
| Tammy Chang, MD, PhD | Liver Injury & Immunology | Cell-matrix interactions; tissue engineering |
| Jennifer Chen, MD | Liver Injury & Immunology | Mechanisms and treatment of hepatic fibrosis |
| Stewart Cooper, MD | Liver Injury & Immunology | Hepatic immunology in viral hepatitis and liver cancer |
| M. Almira Correia, PhD | Liver Regeneration & Clinical Transplantation | Cytochrome P450 regulation; ER stress |
| Markus Delling, PhD | Liver Regeneration & Clinical Transplantation | Primary cilia in liver and other organs |
| Jin Ge, MD, MBA | Liver Injury and Immunology | Chronic liver disease, EHR-based investigation |
| Andrei Goga, MD, PhD | Liver Regeneration & Clinical Transplantation | Mechanisms of hepatocarcinogenesis |
| Emily Goldberg, PhD | Liver Metabolism & Organ Cross-Talk | Ketogenesis in aging and immune consequences |
| Bilal Hameed, MD | Liver Regeneration & Clinical Transplantation | Liver transplantation; fatty liver disease; drug and surgical interventions |
| Chris Hsiung, MD, PhD * | Liver Injury and Immunology | Enhancers promoting hepatic stellate cell activation and liver fibrosis |
| Roarke Kamber, PhD | Liver Injury and Immunology | Kupffer cell-mediated clearance |
| Bridget Keenan, MD, PhD | Liver Regeneration & Clinical Transplantation | Drivers of immunotherapy resistance in hepatobiliary cancers |
| Robin Kate Kelley, MD | Liver Regeneration & Clinical Transplantation | Hepatobiliary malignancies |
| Mandana Khalili, MD, MAS | Liver Injury & Immunology | Viral hepatitis, metabolism, fatty liver disease |
| Jennifer Lai, MD | Liver Regeneration & Clinical Transplantation | Frailty and outcomes in liver transplantation |
| Chris Lau, PhD | Liver Regeneration & Clinical Transplantation | Sex differences in hepatocellular cancer |
| James Lee, MD | Liver Injury & Immunology | Immune mechanisms of checkpoint inhibitor escape in liver metastasis |
| Michael Li, MD, MPH | Liver Injury & Immunology | Immunotherapy for liver disease: response and toxicity |
| Jacquelyn J. Maher, MD | Liver Metabolism & Organ Cross-Talk | Fatty liver disease; mechanisms of liver cell death |
| Ajay Maker, MD | Liver Injury & Immunology | Tumor immunology; hepatic metastasis |
| Aras Mattis, MD, PhD | Liver Metabolism & Organ Cross-Talk | Mechanism of steatohepatitis |
| Marisa Medina, PhD * | Liver Metabolism & Organ Cross-Talk | Cholesterol metabolism and metabolic liver disease; iPSC modeling |
| Ari Molofsky, MD, PhD | Liver Injury & Immunology | Immune regulation of liver fibrosis |
| David Moore, PhD | Liver Regeneration & Clinical Transplantation | Nuclear receptors in metabolism and carcinogenesis |
| Anders Naar, PhD | Liver Metabolism & Organ Cross-Talk | MicroRNAs in the regulation of hepatic metabolism |
| Amar Nijagal, MD | Liver Injury & Immunology | Neonatal hepatic inflammation in biliary atresia and hepatoblastoma |
| Joni Nikkanen, PhD | Liver Injury & Immunology | Neurobiology,metabolism,sex differences,neuroendocrinology,innate immunity and infectious diseases |
| Patrick O'Farrell, PhD | Liver Regeneration & Clinical Transplantation | Mitochondrial DNA integrity and mutations with age |
| Michael Ohliger, MD, PhD | Liver Injury & Immunology | Novel imaging modalitites for liver disease |
| James Olzmann, PhD | Liver Metabolism & Organ Cross-Talk | Lipid droplet biology; lipotoxicity |
| Melanie Ott, MD, PhD | Liver Injury & Immunology | HBV, HCV virology and pathogenesis |
| Jennifer Price, MD | Liver Injury & Immunology | Liver diseae in patients living with HIV |
| Vijay Ramani, PhD | Liver Regenration & Clinical Transplantation | Impact of polyploidy on hepatocyte genome architecture |
| Garertt R. Roll, MD, FACS | Liver Regeneration & Clinical Transplantation | Cell therapy with hepatocytes-like cells derived from stem cells |
| Jessica Rubin, MD, MPH | Liver Injury and Immunology | Pain management in cirrhosis patients |
| Carolyn Sangokoya, MD, PhD | Liver Regeneration & Clinical Transplantation | Cellular iron regulation in liver |
| Monika Sarkar, MD | Liver Metabolism & Organ Cross-Talk | Sex hormone influences on fatty liver disease |
| Andreas Stahl, PhD | Liver Metabolism & Organ Cross-Talk | Liver-adipose axis; metabolic influences on hepatocarcinogenesis |
| Peter G. Stock, MD, PhD | Liver Regeneration & Clinical Transplantation | Solid organ transplants in HIV-infected patients |
| Michele Tana, MD | Liver Injury & Immunology | Pathogenesis of autoimmune liver diseases; health disparities in AIH |
| Sharad Wadhwani, MD, MPH | Liver Regeneration & Clinical Transplantation | Social determinants of health and transplant outcomes in children |
| Bruce Wang, MD | Liver Regeneration & Clinical Transplantation | Factors determining hepatocyte heterogeneity |
| Jen-Chywan Wang, PhD | Liver Metabolism & Organ Cross-Talk | Glucocorticoid regulation of liver metabolism |
| Holger Willenbring, MD, PhD | Liver Regeneration & Clinical Transplantation | Liver regeneration and carcinogenesis; gene therapy; metabolic liver disease |
| Allison Xu, PhD | Liver Metabolism & Organ Cross-Talk | Neural control of hepatic steatosis |
